In Vivo Study on the Pharmacological Interactions between a Chinese Herbal Formula ELP and Antiresorptive Drugs to Counteract Osteoporosis

Figure 5

Alterations in failure strength, ultimate strength and stiffness at the femoral midshaft following 8 weeks of treatment with different combinations of alendronate (a, c, and e) and raloxifene (b, d, and f). Bars represent the mean ± SEM for each treatment group (𝑛=8 per group). Significant difference: *𝑃<0.05; **𝑃<0.01; ***𝑃<0.001 for difference from OVX group without treatment.

(a)

(b)

(c)

(d)

(e)

(f)